Psychologists in Fairfax, CA Accepting Medicare
4 Psychologists found. Showing 1 - 4
 Dr. Marissa A Robinson, PSYD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 155 Frustuck Ave, Fairfax, CA 94930 Phone: 415-754-0451 Fax: 855-344-5560 |
Giovanna A. Otfinowski Psychologist Medicare: Accepting Medicare Assignments Practice Location: 342 Cascade Dr, Fairfax, CA 94930 Phone: 510-336-7077 |
Dr. Sarah Mullin, PH. D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 18 Mountain View Rd, Fairfax, CA 94930 Phone: 415-846-5096 |
 Dr. Max Farber, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 369 Cypress Dr, Fairfax, CA 94930 Phone: 415-290-8920 |
News Archive
Report examines how new technologies can aid in humanitarian response to disasters
A new report examines how new technologies, including digital mapping, can influence emergency relief work and says technology will not be able to fully transform humanitarian aid without "better coordination and communication between digital volunteers and veteran agencies in the relief field, like the United Nations and the Red Cross," the New York Times reports.
Study shows frequent masturbation reduces chance of developing prostate cancer
An Amercian study has shown sexual activity has been hypothesized to play a role in the development of prostate cancer, but epidemiological data are virtually limited to case-control studies, which may be prone to bias because recall among individuals with prostate cancer could be distorted as a consequence of prostate malignancy or ongoing therapy.
Combination of anastrozole and a synthetic hormone called goserelin may slow male breast cancer growth
Medical oncologists across the nation want to know whether a certain drug combination can slow the progression of male breast cancer, a rare disease that often goes undiagnosed until it's in an advanced stage.
Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting
Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.
Evaluation of primary urinary tract infection in infants
They reviewed the clinical and laboratory findings as well as the diagnosis and treatment. This study is important since urinary tract infection is one of the most common causes of unexplained fevers in infants with an overall reported prevalence of approximately 10%. infection.
› Verified 6 days ago
Counselors
Psychologists
Occupational Therapists
Pharmacists
Clinical Social Workers
Dentists